Gabelli Funds LLC Takeda Pharmaceutical CO LTD Transaction History

Gabelli Funds LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$13.17 - $16.4 $3.79 Million - $4.72 Million	-288,057 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$16.3 - $17.26 $36,675 - $38,835	-2,250 Reduced 0.78%	288,057 $4.72 Million
Q1 2021 May 14, 2021	BUY	$16.71 - $19.9 $10,861 - $12,934	650 Added 0.22%	290,307 $5.3 Million
Q4 2020 Feb 05, 2021	SELL	$15.39 - $18.97 $935,019 - $1.15 Million	-60,755 Reduced 17.34%	289,657 $5.27 Million
Q1 2020 May 14, 2020	BUY	$13.02 - $20.31 $2,604 - $4,061	200 Added 0.06%	350,412 $5.32 Million
Q4 2019 Feb 14, 2020	BUY	$16.88 - $20.83 $18,568 - $22,912	1,100 Added 0.32%	350,212 $6.91 Million
Q3 2019 Nov 01, 2019	BUY	$16.15 - $17.99 $6,459 - $7,195	400 Added 0.11%	349,112 $6.01 Million
Q2 2019 Aug 02, 2019	BUY	$16.58 - $20.49 $23,211 - $28,685	1,400 Added 0.4%	348,712 $6.17 Million
Q1 2019 May 02, 2019	BUY	$16.7 - $21.52 $5.8 Million - $7.47 Million	347,312 New	347,312 $7.08 Million

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

Stay updated on Gabelli Funds LLC with notifications on news.